Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c

Allarity Therapeutics (NASDAQ: ALLR) reported Q2 EPS of ($0.15).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

You May Also Be Interested In

• Old Dominion Freight Line (ODFL) Reiterated at Buy by Stifel Amid Seasonally Softer Q4/Q1
• Guggenheim Reiterates Neutral Rating on Lululemon (LULU)
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance